NCT05692466View on ClinicalTrials.gov

"Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting (DINOSAur)"

RecruitingOBSERVATIONAL
Enrollment

572

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2025

Conditions
Stage III Solid TumorsStage IV Solid Tumors
Interventions
DIAGNOSTIC_TEST

Comprehensive molecular panel test

Lab test

OTHER

EORTC QLQ-30

Quality of life questionnaire

Trial Locations (1)

91206

RECRUITING

Adventist Health Glendale, Glendale

Sponsors

Collaborators (1)

Caris Life Sciences
All Listed Sponsors
collaborator

Caris Life Sciences

INDUSTRY

lead

Glendale Adventist Medical Center d/b/a Adventist Health Glendale

OTHER

NCT05692466 - "Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting (DINOSAur)" | Biotech Hunter | Biotech Hunter